These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32705357)

  • 1. Neuropathic Pain and Sickle Cell Disease: a Review of Pharmacologic Management.
    Orhurhu MS; Chu R; Claus L; Roberts J; Salisu B; Urits I; Orhurhu E; Viswanath O; Kaye AD; Kaye AJ; Orhurhu V
    Curr Pain Headache Rep; 2020 Jul; 24(9):52. PubMed ID: 32705357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathic pain in sickle cell disease: measurement and management.
    Glaros A; Brandow AM
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):553-561. PubMed ID: 33275730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report.
    Román ME; Highland J; Retherford D; Pan AY; Panepinto JA; Brandow AM
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28698. PubMed ID: 33034107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathic pain in individuals with sickle cell disease.
    Sharma D; Brandow AM
    Neurosci Lett; 2020 Jan; 714():134445. PubMed ID: 31454562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmet Need: Mechanistic and Translational Studies of Sickle Cell Disease Pain as a Whole-Person Health Challenge.
    Belfer I; Chen W; Weber W; Edwards E; Langevin HM
    J Pain; 2024 Oct; 25(10):104603. PubMed ID: 38878809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathic Pain and Spinal Cord Injury: Phenotypes and Pharmacological Management.
    Widerström-Noga E
    Drugs; 2017 Jun; 77(9):967-984. PubMed ID: 28451808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature.
    Brandow AM; Farley RA; Panepinto JA
    Pediatr Blood Cancer; 2015 Sep; 62(9):1501-11. PubMed ID: 25976161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathic Pain Screening: Construct Validity in Patients With Sickle Cell Disease.
    Powell-Roach K; Yao Y; Ezenwa MO; Schlaeger JM; Suarez ML; Molokie RE; Wang ZJ; Wilkie DJ
    West J Nurs Res; 2020 Feb; 42(2):125-130. PubMed ID: 30900520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Utility of Quantitative Sensory Testing among Adults with Sickle Cell Disease: Indicators of Neuropathic Pain?
    Ezenwa MO; Molokie RE; Wang ZJ; Yao Y; Suarez ML; Pullum C; Schlaeger JM; Fillingim RB; Wilkie DJ
    Pain Pract; 2016 Mar; 16(3):282-93. PubMed ID: 25581383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life and neuropathic pain in sickle cell disease in Jamaica.
    Bartlett R; Ramsay Z; Ali A; Grant J; Rankine-Mullings A; Gordon-Strachan G; Asnani M
    Disabil Health J; 2021 Oct; 14(4):101107. PubMed ID: 33867318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathic pain in patients with sickle cell disease.
    Brandow AM; Farley RA; Panepinto JA
    Pediatr Blood Cancer; 2014 Mar; 61(3):512-7. PubMed ID: 24167104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease.
    Wilkie DJ; Molokie R; Boyd-Seal D; Suarez ML; Kim YO; Zong S; Wittert H; Zhao Z; Saunthararajah Y; Wang ZJ
    J Natl Med Assoc; 2010 Jan; 102(1):18-27. PubMed ID: 20158132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathic pain in people with cancer (part 2): pharmacological and non-pharmacological management.
    Taverner T
    Int J Palliat Nurs; 2015 Aug; 21(8):380-4. PubMed ID: 26312533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sickle cell disease pain management in adolescents: a literature review.
    Wilson BH; Nelson J
    Pain Manag Nurs; 2015 Apr; 16(2):146-51. PubMed ID: 25175555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial and pharmacological management of pain in pediatric sickle cell disease.
    Hildenbrand AK; Nicholls EG; Daly BP; Marsac ML; Tarazi R; Deepti R
    Postgrad Med; 2014 Mar; 126(2):123-33. PubMed ID: 24685976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobiological mechanisms of pain in sickle cell disease.
    Wang ZJ; Wilkie DJ; Molokie R
    Hematology Am Soc Hematol Educ Program; 2010; 2010():403-8. PubMed ID: 21239826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A telephonic mindfulness-based intervention for persons with sickle cell disease: study protocol for a randomized controlled trial.
    Williams H; Silva S; Simmons LA; Tanabe P
    Trials; 2017 May; 18(1):218. PubMed ID: 28506281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.
    Fiocchi J; Urits I; Orhurhu V; Orhurhu MS; Giacomazzi S; Hoyt B; Kaye AD; Kaye RJ; Viswanath O
    Curr Pain Headache Rep; 2020 Mar; 24(5):17. PubMed ID: 32200490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review/overview of pain in sickle cell disease.
    Ballas SK; Darbari DS
    Complement Ther Med; 2020 Mar; 49():102327. PubMed ID: 32147066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How sickle cell disease patients experience, understand and explain their pain: An Interpretative Phenomenological Analysis study.
    Coleman B; Ellis-Caird H; McGowan J; Benjamin MJ
    Br J Health Psychol; 2016 Feb; 21(1):190-203. PubMed ID: 26333530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.